San Francisco, CA - Stroke researchers are calling on physicians to address "head-on" their subconscious biases in treating patients of different races. New research suggests that black stroke ...

February 8, 2007 (San Francisco) — A new study shows that despite the lack of data on safety or efficacy, children with stroke are increasingly receiving treatment with tissue plasminogen activator ...

About 87 percent of all strokes are ischemic, meaning they’re caused by a blood clot in the brain. For more than 20 years, the standard of care has been a drug called TPA. But now, some doctors are ...

About 87 percent of all strokes are ischemic, meaning they’re caused by a blood clot in the brain. For over 20 years, the standard of care has been a drug called TPA. But now, some doctors are ...

An experimental therapy using tiny bubbles activated by transcranial doppler ultrasound combined with the clot busting drug tissue plasminogen activator (tPA) is more effective than tPA alone in ...

Adult patients with sickle cell disease who experience a stroke caused by a clot (i.e., ischemic strokes) can be treated safely with tissue plasminogen activator if they qualify, report investigators.

Medicare for the first time will soon begin reimbursing hospitals specifically for the administration of tissue plasminogen activator in ischemic stroke patients, marking "what promises to create a ...

Neurologist and scientist Justin Zivin helped develop and champion the use of tPA, a clot-busting drug that can minimize the impact of stroke on its victims. One day in late 2009, neurologist Boris ...

Among patients presenting directly to a thrombectomy-equipped center with a large-vessel ischemic stroke, going directly to the endovascular suite and forgoing initial IV thrombolytic therapy provides ...

Commenting on the study's results, lead author Robert J. Adams, MD, said, "Having sickle cell disease did not adversely affect any of the indicators we measured." New research has found that tissue ...

In patients with acute ischemic stroke, endovascular therapy does not provide better outcomes than systemic intravenous (IV) thrombolysis, despite being more effective at opening obstructed vessels, ...

In the largest report on acute stroke in sickle cell disease to date, researchers at the Medical University of South Carolina and elsewhere provide the first systemic evidence for the safe use of tPA ...